The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a proximal molecular phenotype, then a disease-relevant phenotype, in that order.
Curated pathway from expert analysis
flowchart TD
A["Genetic Aging Variants in PD<br/>Epigenetic Clock Acceleration Hypothesis"]
B["Perturbation-First Validation<br/>Senolytics and Epigenetic Interventions"]
C["PD Model Testing<br/>iPSC Neurons or Organoids from PD Patients"]
D["Epigenetic Age Reversal Measurement<br/>DNAm Clock Normalization"]
E["Neuronal Function Restoration<br/>Alpha-Synuclein Aggregation Reduction"]
F["PD Prevention Strategy Validation<br/>Aging-Targeted Intervention Evidence"]
A --> B
B --> C
C --> D
D --> E
E --> F
style A fill:#0d47a1,stroke:#64b5f6,color:#64b5f6
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9aNo linked papers recorded for this hypothesis yet.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for this gene.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.